5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression. (Q54351280)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression. |
scientific article |
Statements
5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression. (English)
1 reference
Donghao Shang
1 reference
Yuting Liu
1 reference
Xiuhong Xu
1 reference
Tiandong Han
1 reference
Ye Tian
1 reference
22 August 2011
1 reference
311
1 reference
2
1 reference
230-236
1 reference
Identifiers
1 reference